Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.

NCT04082806 is registered in ClinicalTrials.gov with Erich Seifritz as lead sponsor.

NCT NCT04082806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04082806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.
Lead sponsor
Erich Seifritz
Phase
Phase 2
Overall status
Completed
Start date
August 6, 2020
Completion date
April 6, 2022
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder